WeForNews | Latest News, Breaking News, News Updates Working on inspection framework for safe food: FSSAI | WeForNews | Latest News, Blogs
Connect with us

Health

Working on inspection framework for safe food: FSSAI

Published

on

FSSAI

New Delhi, Sep 9: The Food Safety and Standards Authority of India (FSSAI) is coming up with a comprehensive inspection framework to ensure supply of safe, hygienic and nutritious food, an official said here on Friday.

“We are working with comprehensive approach which we are calling safe and nutritious food shared responsibility, in which we are trying to reach out to Indian homes, schools, work places, restaurants, street food vendors, railways, temples,” FSSAI Chief Executive Officer Pawan Agarwal said at a FICCI event.

“On the food practices standards, we are very much far behind and this is one area of focus where we depend quite extensively on professionals who work in the food industry. We are somewhat unfortunate that general awareness about standards of food safety and hygiene is very low.”

Agarwal said that a new regulatory arrangement was being put in place to support the enforcement of regulations.

He said there were about 135 food laboratories set up by the private sector, which were recognised by the FSSAI, in addition to 90 government laboratories, most of which are under state governments’ control.

He said the FSSAI did not have food inspectors as food inspection was largely done by state governments.

Asking the food industry for collaboration, the FSSAI chief said: “Our efforts should be building coalition of stakeholders, who can jointly take responsibility. If we join hands together, our number of food inspectors will go above 20,000 in US.”

He said the FSSAI worked with science organisations, research institution to create standards for food business to operate in this country.

“A lot of progress is made. About 80-85 per cent of standards are in place. And balance 10-12 per cent is in final stages of being notified,” he said.

“We continue to give all newer and better standards to provide scope for innovation for food industry and global benchmark as far as new products and service is concerned.”

The FSSAI has released the ‘Yellow Book’ that was aimed at children detailing how to eat right with emphasis on preventing nutritional deficiencies and making healthy choices.

Agarwal said the book was launched in three categories for children in different age groups and it covered a range of topics — from food safety practices, personal hygiene and cleanliness habits, and eating a balanced diet to packing a wholesome lunch box.

He said it can be adopted across schools through state education machineries as part of their curricular and co-curricular activities.

IANS

Cities

Delhi reports 51 cases of minor adverse events post vaccination

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Published

on

By

Covid 19 Vaccine

Hours after the Health Ministry announced on January 16 that India has reported no case of post-vaccination hospitalisation yet, 51 persons complained of minor adverse events in Delhi. Another person developed severe adverse event following immunization and had to be referred to the AEFI centre.

Out of a total of 4,319 healthcare and frontline workers who were vaccinated on Jnauary 16 in the National Capital, two healthcare workers at NDMC’s Charak Palika Hospital reported mild adverse event post-vaccination including mild tightness in the chest. They were kept under observation by AEFI team and discharged 30 minutes later after they felt at ease. The two other cases were reported from Northern Railway Central Hospital, of which one was referred to the AEFI centre, the Delhi government has informed.

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Beneficiaries from 11 states and union territories across India received Covishield or Covaxin shots on the first day of the vaccination drive, namely, Assam, Bihar, Delhi, Haryana, Karnataka, Maharashtra, Odisha, Rajasthan, Tamil Nadu, Telangana, and Uttar Pradesh.

Follow our coverage of the coronavirus crisis here

Continue Reading

Health

Bharat Biotech to pay compensation if Covaxin causes side-effects

The vaccine maker said in phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19

Published

on

By

COVAXIN Corona Covid vaccine

Hyderabad, January 16: Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company would pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote.

In the consent form to be signed by the vaccine recipients, Bharat Biotech said: “In case of any adverse events or serious adverse events, you will be provided medically recognised standard of care in the government designated and authorised centres/hospitals.”

“The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine,” the consent form said.

In phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19. However, the clinical efficacy of the vaccine was yet to be established and it was still being studied in phase 3 clinical trials, the vaccine maker said.

“Hence it is important to appreciate that receiving the vaccine does not mean that other precautions related to COVID-19 need not be followed,” the consent form said.

According to an industry expert, the company is liable to pay compensation to people in case of serious side effects as the vaccine is being administered while in the clinical trial mode.

The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in public interest as an abundant caution, in clinical trial mode.

Meanwhile, Suchitra Ella, joint managing director, Bharat Biotech International Limited, on her Twitter account said: “Covaxin & Bharat Biotech is truly humbled & honoured to be of service to the nation & the fraternity of all first responders of covid who have served public health.” — PTI

Continue Reading

Cities

AIIMS security guard reports allergy post COVID vaccination, in hospital care

Delhi has reported 52 adverse events following events of which one is serious and could involve the guard hospitalised today.

Published

on

By

Vaccine

New Delhi, January 16

A 22-year-old security guard at AIIMS, New Delhi reported allergic reaction and is learnt to be in intensive care, moments after the government said there was no post-vaccine hospitalisation.

The 22-year-old guard developed headache, rash, respiratory distress, tachycardia after vaccination. He is in ICU and his condition is stable, hospital sources said.

Delhi has reported 52 adverse events following events of which one is serious and could involve the guard hospitalised today.

All beneficiaries vaccinated at AIIMS got indigenous COVAXIN.

Continue Reading
Advertisement

Most Popular